Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06830811 · ClinicalTrials.gov registry record · NA
Bone Mineral Density Precision Study
A NA study of Indicated for EOSedge Imaging, sponsored by Alphatec Spine.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06830811: Recruiting NA study of Indicated for EOSedge Imaging, sponsored by Alphatec Spine.
NCT06830811 is a NA study of Indicated for EOSedge Imaging that is actively recruiting participants, run by Alphatec Spine. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06830811, a NA study of Indicated for EOSedge Imaging, is actively recruiting participants, sponsored by Alphatec Spine.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two low-dose x-ray exams. The main question it aims to answer is: What is the precision measurement between the BMD assessments from 2 x-ray exams?
Primary Outcome
Calculation of EOSedge BMD from the 2 exams will be post-processed from the bi-planar EOSedge 2E radiographs, and is measured in g/cm² surface mass on four lumbar vertebrae (L1-L4) in the anteroposterior (AP) projection. Precision error will be calculated from the 2 exams.
Conditions Studied
Interventions
- RADIATION EOSedge imaging
Study Locations (1)
Indiana
- OrthoIndy - Fishers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2025-03 |
| Phase | NA |
What NCT06830811 shows while recruiting
NCT06830811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Indicated for EOSedge Imaging appearing as the primary indexed condition, and to 1 intervention - of which EOSedge imaging is the first listed.
NCT06830811 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06830811 about?
NCT06830811 is a clinical study titled "Bone Mineral Density Precision Study". The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two low-dose x-ray exams. The main question it aims to answer is: What is the precision measurement between the BMD assessments from 2 x-ray exams?
What is the current status of trial NCT06830811?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-11-13. Estimated completion is 2025-03.
What conditions does trial NCT06830811 study?
This clinical trial studies the following conditions: Indicated for EOSedge Imaging.
What interventions are being tested in trial NCT06830811?
The interventions under investigation include: EOSedge imaging (RADIATION).
Who is sponsoring clinical trial NCT06830811?
This trial is sponsored by Alphatec Spine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06830811 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Indicated for EOSedge Imaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06830811's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI